Test
Text
Israeli CAR-T cancer treatment could be administered out-patient – first in the world
Israeli CAR-T cancer treatment could be administered out-patient – first in the worldThe therapy was developed at Hadassah to treat Multiple Myeloma, AL Amyloidosis and other BCMA-positive malignancies. Israeli cancer treatment is en route to becoming the world’s first and only out-patient CAR-T for multiple myeloma, AL amyloidosis and other BCMA-positive malignancies. Prof. Polina Stepensky […]
Jerusalem’s Hadassah medical center named global leader in several fields
Newsweek has named Jerusalem’s Hadassah Medical Center a world leader in oncology and for the fifth straight year one of the globe’s top hospitals in both cardiology and smart technology. The rankings appeared in the World’s Best Hospitals 2023, the fifth annual assessment of 300 hospitals in 28 countries produced by Newsweek, in partnership with the global data […]
Hadassah Appoints New Emergency Room Director
Dr. Ahmed Naama was appointed the new director of the Emergency Medicine Department (Emergency Room) at Hadassah Ein Kerem Hospital, Jerusalem, Israel. Naama, an expert in emergency medicine and the management of acute emergencies and trauma, replaced Prof. Kobi Assaf, who was appointed as the director of the emergency medicine unit at the Hadassah Medical […]
Israeli Humanitarian Aid Delegation Departs for Türkiye
‘We’ll do our best to save lives’: IDF rescue delegation arrives in southern Turkey
Prof. Polina Stepensky Explains The CAR (Chimeric Antigen Receptor) T-Cell Therapy.
Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today that they have entered into the research and license agreement with Immix BioPharma, for the development and commercialization of novel tissue specific therapeutics based on anti-BCMA CAR-T cells targeting plasma cell. This technology has been developed as the result of a collaboration between Prof. Polina Stepensky, of Hadassah Medical Center, Jerusalem and Prof. Cyrille J. Cohen, of Bar-Ilan University, Ramat Gan. Dr. Shlomit Kfir-Erenfeld and Dr. Nathalie Asherie, of Hadassah Medical Center, and Ortal Harush, of Bar-Ilan University, also participated in the research.
For more information visit Yahoo! Finance
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms
Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
COVID-19 vaccine provides effective protection against Omicron pregnancy risks
Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm’s China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.
(photo credit: REUTERS/FLORENCE LO)
Hadassah Hospital’s First Babies Of 2023
The celebration of new life is a momentous moment at the dawn of a new year. Hadassah Hospital is delighted to welcome its firstborn of 2023. At the stroke of midnight at Hadassah Mount Scopus, a sweet baby girl was born to Reut and Harel, adding to their ever-growing family of three children – all […]
Technology helping Israel cure cancer in children
“Other than genomics, the other reason why the survival rate is high is due to better diagnostic tools that allow doctors to get a better view into how patients are responding to treatments and improve their ability to provide personalized care,” said Dr. Goldstein.
